Activist 13D/13G Filings - ROCHE FINANCE LTD

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2024-02-14
4:12 pm
Sale		13GENTRADA THERAPEUTICS INC
TRDA		ROCHE FINANCE LTD2,744,120
8.2%		-69,405decrease
(-2.47%)		View
2023-11-07
5:16 pm
Purchase		13GALIGOS THERAPEUTICS INC
ALGS		ROCHE FINANCE LTD11,025,941
15.35%		7,933,601increase
(+256.56%)		View
2023-02-13
4:52 pm
Sale		13GELOXX PHARMACEUTICALS INC
ELOX		ROCHE FINANCE LTD1,893
0.1%		-4,997,043decrease
(-99.96%)		View
2023-02-13
4:49 pm
Unchanged		13GJASPER THERAPEUTICS INC
JSPR		ROCHE FINANCE LTD4,624,606
4.2%		0
(Unchanged)		View
2022-02-14
06:20 am
Purchase		13GTEMPEST THERAPEUTICS INC
TPST		ROCHE FINANCE LTD72,612
1.1%		72,612increase
(New Position)		View
2022-02-14
06:19 am
Sale		13GVAXCYTE INC
PCVX		ROCHE FINANCE LTD2,334,113
4.4%		-253,641decrease
(-9.80%)		View
2022-02-14
06:19 am
Purchase		13GENTRADA THERAPEUTICS INC
TRDA		ROCHE FINANCE LTD2,813,525
9%		2,813,525increase
(New Position)		View
2022-02-14
06:18 am
Sale		13GALLAKOS INC
ALLK		ROCHE FINANCE LTD2,629,157
4.8%		-1,916,566decrease
(-42.16%)		View
2022-02-14
06:18 am
Purchase		13GELOXX PHARMACEUTICALS INC
ELOX		ROCHE FINANCE LTD4,998,936
5.8%		2,466,666increase
(+97.41%)		View
2021-10-04
08:54 am
Purchase		13GJASPER THERAPEUTICS INC
JSPR		ROCHE FINANCE LTD4,624,606
12.7%		4,624,606increase
(New Position)		View
2021-06-14
4:01 pm
Purchase		13GELOXX PHARMACEUTICALS INC
ELOX		ROCHE FINANCE LTD2,532,270
5.3%		2,532,270increase
(New Position)		View
2021-03-02
4:15 pm
Sale		13GSENSEONICS HLDGS INC
SENS		ROCHE FINANCE LTD17,523,209
4.7%		-10,822,066decrease
(-38.18%)		View
2021-02-16
07:03 am
Purchase		13GALLAKOS INC
ALLK		ROCHE FINANCE LTD4,545,723
9.3%		1,766,566increase
(+63.56%)		View
2021-02-16
07:03 am
Purchase		13GALIGOS THERAPEUTICS INC
ALGS		ROCHE FINANCE LTD3,092,340
8.1%		3,092,340increase
(New Position)		View
2021-02-16
07:02 am
Purchase		13GPANDION THERAPEUTICS INC
PAND		ROCHE FINANCE LTD3,086,084
10.5%		3,086,084increase
(New Position)		View
2021-02-16
07:02 am
Purchase		13GVAXCYTE INC
PCVX		ROCHE FINANCE LTD2,587,754
5.1%		2,587,754increase
(New Position)		View
2021-02-16
07:02 am
Unchanged		13GMILLENDO THERAPEUTICS INC
MLND		ROCHE FINANCE LTD1,089,180
5.7%		0
(Unchanged)		View
2021-02-16
07:01 am
Purchase		13GALLAKOS INC
ALLK		ROCHE FINANCE LTD2,779,157
5.3%		2,779,157increase
(New Position)		View
2021-02-16
07:01 am
Purchase		13GSENSEONICS HLDGS INC
SENS		ROCHE FINANCE LTD28,345,275
11.5%		28,345,275increase
(New Position)		View
2020-03-17
09:08 am
Purchase		13GMILLENDO THERAPEUTICS INC
MLND		ROCHE FINANCE LTD1,089,180
6.2%		333,333increase
(+44.10%)		View